System Constellations in Virtual Reality (VR)
- Conditions
- Psychological and Systems Functioning
- Registration Number
- NCT05557890
- Lead Sponsor
- University of Witten/Herdecke
- Brief Summary
The purpose of this study is to investigate the efficacy of system constellations in Virtual Reality (VR) in a monocentric, single-masked randomized controlled trial.
The method of system constellations refers to an approach which integrates ideas from organizational and family systems counseling with elements from psychodrama. The constellations are conducted in a group based VR-seminar, each VR-seminar lasting two to three days.
Based on the model of a general mental health, the effects of system constellations in VR on psychological and systems functioning are explored.
It is predicted that participation in a system constellation VR-seminar changes the level of psychological and systems functioning at 4 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 53
- agreement to participate in a 2 to 3-day system constellations VR-seminar
- agreement to be randomized into treatment group or control group (waiting condition)
- agreement not to participate in another system constellation VR-seminar or seminar until completion of study
- acute suicidal tendency
- acute psychotic episode
- acute drug or alcohol intoxication
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change from Baseline EB-45 Score within 4 months Baseline, 2 weeks after treatment, 4 months after treatment Changes in psychological well-being will be assessed using the 'Outcome Questionnaire' in its German version (EB-45). The EB-45 is a brief 45-item self report outcome/tracking instrument designed for repeated measurement of client progress through the course of psychotherapy and following termination. The scales of the EB-45 measure symptom distress, interpersonal functioning, and social role.
- Secondary Outcome Measures
Name Time Method Incongruence Questionnaire (K-INK) Baseline, 2 weeks after treatment, 4 months after treatment Motivational incongruence is defined as the unsatisfactory realization of motivational goals and is based on the concept of General Psychotherapy by Klaus Grawe. The Incongruence Questionnaire (INK) is an instrument that assesses motivational incongruence, defined as the discrepancy between a person's motivational goals and his/her perception of reality. The short version of this questionnaire that will be used in our study (K-INK) comprises 23 items.
Experience in Social Systems Questionnaire (EXIS) Baseline, 2 weeks after treatment, 4 months after treatment The subjective quality of family and organizational systems will be assessed by the EXIS (Questionnaire on experiences in systems), a self-constructed questionnaire comprising 24 items.
Questionnaire for the Evaluation of Treatment Progress (FEP-2) Baseline, 2 weeks after treatment, 4 months after treatment The FEP-2, 40-item self report questionnaire, measures psychological distress according to the phase model of therapeutic change as well as the interpersonal model of psychological distress.
Bern Inventory of Psychotherapy Goals (BIT-C) Baseline, 2 weeks after treatment, 4 months after treatment Goal achievement will be assessed using Goal Attainment Scaling as a method for the assimilation of achievement in a number of individually set goals into a single aggregated 'goal attainment score', providing a person-centred outcome, focused on that individual's priorities. Goal attainment scaling is operationalized by an open-ended question, in which study participants descriobe their individual goals. In a second step these goals will be coded according to the Bern inventory of psychotherapy goals (BIT-C)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Witten/Herdecke University
🇩🇪Witten, North Rhine-Westphalia, Germany
Witten/Herdecke University🇩🇪Witten, North Rhine-Westphalia, Germany